Perrigo Company plc (NYSE: PRGO), an American-Irish manufacturer of health and wellness products, on Wednesday announced a 5% increase in its quarterly dividend.
The company has increased its quarterly cash dividend to USD0.290 per share, or USD1.16 per share on an annual basis, from USD0.276 per share.
Shareholders of record at 7 March 2025 will receive the dividend on 25 March 2025.
Poxel to receive royalties and sales-based payment from Sumitomo Pharma
ReciBioPharm secures grant to expand RNA manufacturing in LMICs
CVS Health to pays common stock quarterly dividend of USD0.665 per share
TC BioPharm receives shareholders' approval for 25% stock dividend
USANA Health Sciences acquires controlling stake in Hiya Health for USD205m
Valneva and Serum Institute of India partner to expand chikungunya vaccine access in Asia
Lilly and EVA Pharma granted regulatory approval for locally manufactured insulin in Egypt
Abbott announces dividend increase and 53 years of growth
SK bioscience begins clinical trials for mRNA Japanese encephalitis vaccine
Moberg Pharma's MOB-015 fails to meet primary endpoint in phase 3 study